Redcliffe Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-07-2024
- Paid Up Capital ₹ 0.23 M
as on 29-07-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
About Redcliffe Lifescience
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.23 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Kandoi, Dhiraj Jain, Ashish Dubey, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999UP2017PTC199379
- Company No.
070597
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2017
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Redcliffe Lifescience?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Kandoi  | Additional Director | 12-Apr-2024 | Current |
Dhiraj Jain  | Director | 01-Sep-2017 | Current |
| Ashish Dubey | Director | 01-Mar-2023 | Current |
| Radhika Bagla | Director | 01-Aug-2023 | Current |
| Rohit Jalan | Additional Director | 12-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Redcliffe Lifescience.
Enhance accessibility to Redcliffe Lifescience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Redcliffe Lifescience?
In 2023, Redcliffe Lifescience had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Standard Diagnostics Private LimitedActive 4 years 8 monthsAshish Dubey and Radhika Bagla are mutual person
Redcliffe Lifetech Private LimitedActive 3 years 10 monthsAditya Kandoi, Dhiraj Jain and 3 more are mutual person
Crysta Ivf Life Private LimitedActive 3 years 10 monthsRadhika Bagla and Rohit Jalan are mutual person
- Redcliffe Life Images Private LimitedActive 3 years 2 months
Aditya Kandoi, Dhiraj Jain and 3 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Redcliffe Lifescience?
Redcliffe Lifescience has a workforce of 29 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Redcliffe Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redcliffe Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
